Abiologics uses AI to design biologic drugs with non-standard amino acids for immunology and cancer, backed by $50 million from Flagship Pioneering.
GRO Biosciences secures $60 million for gout drug candidate engineered to avoid immune response, led by Atlas Venture and Access Biotechnology.
Collection
[
|
...
]